The interrelation of the angiotensin and endothelin systems on the modulation of NAD(P)H oxidase

Author： Laplante Marc-André   de Champlain Jacques  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.84, Iss.1, 2006-01, pp. : 21-28

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statin Attenuates High Glucose-Induced and Angiotensin II-Induced MAP Kinase Activity Through Inhibition of NAD(P)H Oxidase Activity in Cultured Mesangial Cells

By  

Medicinal Chemistry, Vol. 1, Iss. 5, 2005-09 ,pp. : 461-468

Bentham Science Publishers

Access to resources Recommend Favorite

A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase

By  

Current Medicinal Chemistry, Vol. 10, Iss. 17, 2003-09 ,pp. : 1759-1764

Bentham Science Publishers

Access to resources Recommend Favorite

NAD(P)H Oxidase Activation: A Potential Target Mechanism for Diabetic Vascular Complications, Progressive &bgr;-Cell Dysfunction and Metabolic Syndrome

By  

Current Drug Targets, Vol. 6, Iss. 4, 2005-06 ,pp. : 495-501

Bentham Science Publishers

Access to resources Recommend Favorite

NAD(P)H: QUINONE OXIDOREDUCTASE POLYMORPHISM AND LUNG CANCER IN TAIWAN

By Lin Pinpin   Wang Hsiu-Jen   Lee Huei   Lee Hong-Shen   Wang Shu-Li   Hsueh Yu-Mei   Tsai Kan-Jen   Chen Chih-Yi  

Journal of Toxicology and Environmental Health, Vol. 58, Iss. 4, 1999-10 ,pp. : 187-197

Taylor & Francis Ltd

Access to resources Recommend Favorite

The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases

By Cai H.   Griendling K.K.   Harrison D.G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 9, 2003-09 ,pp. : 471-478

Elsevier

Access to resources Recommend Favorite